Insights
Search Results
News Articles
6.02.26
CBLJ Recognizes Wilson Sonsini During 2026 China Business Law Awards
On May 28, 2026, Wilson Sonsini was recognized as a top international law firm for cross-border arbitration during China Business Law Journal's 2026 China Business Law Awards. The awards recognize law firms with comprehensive service offerings and strong national reputations across China’s legal market.
Client Highlights
5.22.26
Wilson Sonsini Advises WuXi AppTec on Issuance of RMB6,780 Million USD Settled Zero Coupon Convertible Bonds Due 2027
On May 21, 2026, all the conditions precedent under the subscription agreement dated May 14, 2024, entered into between WuXi AppTec Co., Ltd. (WuXi AppTec), Morgan Stanley Asia Limited, Citigroup Global Markets Limited, and Goldman Sachs (Asia) L.L.C. have been fulfilled and the issuance of the RMB6,780 million USD settled zero coupon convertible bonds due 2027 (the Bonds) in an aggregate principal amount of RMB6,780 million was completed. The net proceeds from the subscription of the Bonds, after deducting the managers’ commissions and expenses in connection with the offering, will be approximately US$1,023 million, and will be utilized in the following manner: (a) approximately 90 percent will be used for global capacity and capability expansion and (b) approximately 10 percent will be used for general corporate purposes. A formal application has been made to the Vienna Stock Exchange for the listing of the Bonds on the Vienna Stock Exchange.
News Articles
3.18.26
Wilson Sonsini, Weiheng Chen Shortlisted for 2026 ALB China Law Awards
On March 18, 2026, Asian Legal Business published its shortlist for the 2026 ALB China Law Awards, which celebrate the outstanding performance of private practitioners and in-house teams in China. Wilson Sonsini has been named a finalist for "International Law Firm of the Year" and partner Weiheng Chen has been shortlisted for "Dealmaker of the Year – International."
News Articles
3.03.26
Wilson Sonsini-Led Deals Named Among CBLJ's "2025 Deals of the Year"
On March 3, 2026, China Business Law Journal announced the winning deals for its 2025 Deals of the Year, an annual list which recognizes the past year’s most remarkable transactions and cases. The publication selected 275 standout deals and cases from thousands of submissions based on deal size, industry impact, structural innovation, judicial precedent setting, and social contribution.
Client Highlights
2.11.26
Wilson Sonsini Secures HKIAC Arbitration Victory for Clients
On February 6, 2026, the Hong Kong International Arbitration Centre (HKIAC) issued a partial award (the Partial Award) in a dispute between Leed Education Holding Limited, National Education Holding Limited, and Hyde Education Holding Limited (collectively, the Claimants) and Minsheng Vocational Education Company Limited (the Respondent), a subsidiary of Minsheng Education Group Company Limited (Minsheng Education). Wilson Sonsini represents the Claimants in the arbitration.
Client Highlights
1.28.26
Wilson Sonsini Advises Boyu Capital on $110 Million Convertible Bond Investment in Gushengtang
On January 26, 2026, Gushengtang Holdings Limited (Gushengtang) announced that it had entered into a subscription agreement with an investment vehicle of Boyu Capital for the issuance and subscription of convertible bonds of Gushengtang in the aggregate principal amount of $110 million.
Client Highlights
11.13.25
Wilson Sonsini Advises Huanxi Media on Strategic AI Cooperation with Stepfun
On November 11, 2025, Huanxi Media Group Limited announced that it has entered into a strategic framework agreement with Shanghai Stepfun Intelligent Technology Co., Ltd. to establish a joint venture aimed at leveraging artificial intelligence and large model technologies.
Client Highlights
10.28.25
Wilson Sonsini Advises WuXi AppTec on Sale of China-Based Clinical Research Services Business to Hillhouse
On October 24, 2025, WuXi AppTec Co., Ltd. (WuXi AppTec), a leading global provider of R&D and manufacturing-enabling services in the pharmaceutical, biotechnology, and medical device industries, announced that its wholly owned subsidiary has entered into a sale and purchase agreement to sell its two subsidiaries, WuXi Clinical Development Services (Shanghai) Co., Ltd. (WuXi Clinical) and WuXi MedKey Med-Tech Development (Shanghai) Co., Ltd. (WuXi MedKey), to Hillhouse Investment Management (Hillhouse), one of the world’s leading global private asset managers focusing on sectors such as healthcare, manufacturing, green energy, hard technology, and consumer technology. WuXi Clinical and WuXi MedKey are the operating entities of WuXi AppTec engaged in China-based clinical research services.
Wilson Sonsini Goodrich & Rosati advised WuXi AppTec on the transaction. The Wilson Sonsini team includes:
Wilson Sonsini Goodrich & Rosati advised WuXi AppTec on the transaction. The Wilson Sonsini team includes:
Client Highlights
7.31.25
Wilson Sonsini Advises WuXi AppTec on $980 Million H Shares Placing
On July 31, 2025, WuXi AppTec Co., Ltd. (WuXi AppTec) announced that it has entered into a placing agreement with Morgan Stanley Asia Limited, Citigroup Global Markets Limited, Goldman Sachs (Asia) L.L.C., and The Hongkong and Shanghai Banking Corporation Limited (the Placing Agents), pursuant to which WuXi AppTec has agreed to appoint the Placing Agents and the Placing Agents have severally (but not jointly, nor jointly and severally) agreed to act as the agents of WuXi AppTec and to use their best efforts to procure certain investors to subscribe for a total of 73,800,000 new H Shares at HK$104.27 per placing share to be issued by WuXi AppTec under the general mandate upon the terms and subject to the conditions set out in the placing agreement (the Placing). The Placing is expected to raise $980 million to support WuXi AppTec’s global expansion.
News Articles
7.31.25
Wilson Sonsini, Weiheng Chen Shortlisted in 2025 ALB Hong Kong Law Awards
Asian Legal Business announced the finalists for its 24th annual ALB Hong Kong Law Awards, which celebrate the outstanding performance of private practitioners and in-house teams in Hong Kong. Wilson Sonsini Goodrich & Rosati has been named a finalist for "Deal Firm of the Year."
Client Highlights
7.03.25
Wilson Sonsini Secures Refusal of Application for Urgent Anti-Suit Injunction on Behalf of Sinovac at Hong Kong High Court
On June 27, 2025, Deputy High Court Judge Jonathan Wong of the High Court of Hong Kong ruled in favor of Sinovac Biotech, Ltd. (Sinovac), 1Globe Capital LLC (1Globe), and OrbiMed Partners Master Fund Limited (OrbiMed), refusing Prime Success, L.P.’s ex parte application for urgent injunctive relief in aid of arbitration. The court also declined an application by Vivo Capital, LLC and its affiliates to join the ex parte application.